使fMRI,CNGB3

Elaine J Anderson1, Tessa M Dekker2, Mahtab Farahbakhsh2

  • 1UCL Institute of Ophthalmology, University College London, UK; UCL Institute of Cognitive Neuroscience, University College London, UK; The Wellcome Centre for Human Neuroimaging, University College London, UK.

PubMed
概括

基因治疗非色素 (ACHM) 显示了有限的群体效应,但为个人恢复提供了希望. 一名患有CNGB3-ACHM的患者在治疗后经历了色彩视觉和大脑活动的改善.